Informationen:
Fehler:
ID
33351
Beschreibung
Efficacy and Safety of BMS-690514 in Combination With Letrozole to Treat Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01068704
Link
https://clinicaltrials.gov/show/NCT01068704
Stichworte
Versionen (1)
- 06.12.18 06.12.18 -
Rechteinhaber
See clinicaltrials.gov
Hochgeladen am
6. Dezember 2018
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Breast Cancer NCT01068704
Eligibility Breast Cancer NCT01068704
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Breast Cancer NCT01068704
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Invasive carcinoma of breast
Item
documented invasive breast cancer
boolean
C0853879 (UMLS CUI [1])
Neoplastic Cell Percentage Estrogen receptor positive | Neoplastic Cell Percentage Progesterone receptor positive
Item
greater than 10% tumor cells positive for estrogen receptor and/or progesterone receptor
boolean
C0597032 (UMLS CUI [1,1])
C0439165 (UMLS CUI [1,2])
C0279754 (UMLS CUI [1,3])
C0597032 (UMLS CUI [2,1])
C0439165 (UMLS CUI [2,2])
C0279759 (UMLS CUI [2,3])
C0439165 (UMLS CUI [1,2])
C0279754 (UMLS CUI [1,3])
C0597032 (UMLS CUI [2,1])
C0439165 (UMLS CUI [2,2])
C0279759 (UMLS CUI [2,3])
Disease HER2 Positive | Disease HER2 Negative
Item
her2+ and her2- (human epidermal growth factor receptor) disease
boolean
C0012634 (UMLS CUI [1,1])
C2348909 (UMLS CUI [1,2])
C0012634 (UMLS CUI [2,1])
C2348908 (UMLS CUI [2,2])
C2348909 (UMLS CUI [1,2])
C0012634 (UMLS CUI [2,1])
C2348908 (UMLS CUI [2,2])
Rapid disease progression | Tamoxifen | anastrozole | exemestane
Item
rapid disease progression despite treatment with tamoxifen, anastrozole or exemestane
boolean
C1834700 (UMLS CUI [1])
C0039286 (UMLS CUI [2])
C0290883 (UMLS CUI [3])
C0851344 (UMLS CUI [4])
C0039286 (UMLS CUI [2])
C0290883 (UMLS CUI [3])
C0851344 (UMLS CUI [4])
ECOG performance status
Item
ecog performance status = 0 or 1
boolean
C1520224 (UMLS CUI [1])
Prior Hormone Therapy Neoplasm Metastasis
Item
prior hormonal therapy for metastatic disease
boolean
C1514460 (UMLS CUI [1,1])
C0027627 (UMLS CUI [1,2])
C0027627 (UMLS CUI [1,2])
Prior Hormone Therapy Letrozole | Other Coding
Item
prior hormonal therapy with letrozole for adjuvant disease
boolean
C1514460 (UMLS CUI [1,1])
C0246421 (UMLS CUI [1,2])
C3846158 (UMLS CUI [2])
C0246421 (UMLS CUI [1,2])
C3846158 (UMLS CUI [2])
Metastatic malignant neoplasm to brain Symptomatic
Item
symptomatic brain metastases
boolean
C0220650 (UMLS CUI [1,1])
C0231220 (UMLS CUI [1,2])
C0231220 (UMLS CUI [1,2])
Tyrosine kinase inhibitor
Item
prior treatment with any tyrosine kinase inhibitor
boolean
C1268567 (UMLS CUI [1])